Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Wikipedia Affiliate Button

Home > Press > Mills & Reeve helps nanoTherics Limited secure £1m investment: National law firm Mills & Reeve has advised successful technology company, nanoTherics Limited, in relation to a new investment round of over £1 million.

Abstract:
The investment was made by a syndicate of investors, including existing investor Mercia Technology Seed Fund, Advantage Enterprise & Innovation Fund (managed by Catapult Venture Managers) and a number of business angels.

Mills & Reeve helps nanoTherics Limited secure £1m investment: National law firm Mills & Reeve has advised successful technology company, nanoTherics Limited, in relation to a new investment round of over £1 million.

Cambridge, UK | Posted on May 30th, 2011

Corporate finance solicitor Pippa Pearce led the Mills & Reeve team representing the highly innovative life sciences company, which develops and commercialises innovative magnetic nanoparticle based products in the gene therapy research market.

nanoTherics was spun out from Keele University in 2007 following 30 years of combined leading edge research into the use of magnetic nanoparticles for biomedical applications conducted at Keele University and the University of Florida.

The company provides unique scientific devices and associated reagents designed to significantly improve uptake of biomaterials into cells, a process referred to as transfection, to greatly facilitate research into gene-related diseases and disorders. The company's mission is to become the leading supplier of intellectual property protected magnetic nanoparticle-based devices and consumables for transfection, providing superior performance products addressing a global market and underpinning the research and development of current and future drug and genetic screening and gene therapy programmes.

The investment took place on two tranches, with the first tranche completing in August 2010 and the second in January 2011. Dr Linda Cammish, CEO of nanoTherics said: "The funding has come at the appropriate time to allow nanoTherics to further develop its innovative technologies and products and improve research into genetic disease disorders, from Alzheimer's to cancer. This investment represents a critical point in the company's growth strategy and will enable us to place additional resources into the commercialism of our products."

Dr Mark Payton, Fund Principal at Mercia added: "We're delighted to continue to support nanoTherics in the development of its scalable and disruptive products and look forward to the next exciting step in the company's growth plan." He went on to say: "Mills & Reeve's venture capital team provided vital support in helping us complete this round - their experience and expertise in advising on sometimes complex syndicated investments in early stage and developing high-tech businesses was invaluable."

Pippa Pearce was assisted on the transaction by corporate lawyers, Dona Ardeman and Danielle Gibson and technology solicitor Nicola Kenward. Pippa commented: "We are pleased to have been able to assist this ambitious technology company raise the finance needed to ramp up commercialisation of its exciting products. We will follow their progress with interest."

Advantage Enterprise & Innovation Fund were advised by West Midlands firm George Green, led by partner Guy Green and assisted by Philip Round.

####

About Cambridge Network
With offices located in Cambridge, Norwich, Birmingham, Leeds, Manchester and London, Mills & Reeve is one of the UK's largest law firms, offering the full range of corporate and commercial services.

Our Cambridge office includes a specialist IP team dedicated to advising the region's technology companies and we have a close working relationship with Trask Britt, a specialist intellectual property firm based in the US.

We have over 80 qualified lawyers operating from our Norwich and Cambridge offices; with 23 partners leading teams in commercial, tax, banking, corporate finance, pensions, disputes and regulatory matters, with a specific focus on technology-based companies, advising on IP/IT, environmental, health and safety and related property issues.

We were also selected as one of the top three firms by The Lawyer magazine's prestigious 'Law Firm of the Year Award', Mills & Reeve was listed in the Sunday Times '100 Best Companies to Work For' for the seventh year running.

For more information, please click here

Contacts:
Francis House, 112 Hills Road, Cambridge
Postcode: CB2 1PH
United Kingdom
Tel: 44 01223 364422
Fax: 44 01223 355848

www.mills-reeve.com/

Copyright © Cambridge Network

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) June 22nd, 2019

Next-gen solar cells spin in new direction: Phosphorene shows efficiency promise June 21st, 2019

Researchers report new understanding of thermoelectric materials: Discovery leads to promising new materials for converting waste heat to power June 21st, 2019

Millions with neurological diseases could find new option in implantable neurostimulation devices June 21st, 2019

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

180 Degree Capital Corp.ís Portfolio Company, TheStreet, Inc., Enters into Agreement to be Acquired by TheMaven, Inc. for $16.5 Million June 13th, 2019

180 Degree Capital Corp. Reports Net Asset Value per Share of $2.76 as of March 31, 2019; an Increase of 4.5% From December 31, 2018 May 1st, 2019

180 Degree Capital Corp. to Report First Quarter 2019 Financial Results on Wednesday, May 1, 2019 and to Host a Conference Call on Thursday, May 2, 2019 April 26th, 2019

A Nanobiotechnology Startup from a small town in India attracts the Global Investors January 27th, 2019

Nanomedicine

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) June 22nd, 2019

'Nanoemulsion' gels offer new way to deliver drugs through the skin: Novel materials made with FDA-approved components could deliver large payloads of active ingredients June 21st, 2019

Millions with neurological diseases could find new option in implantable neurostimulation devices June 21st, 2019

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-APOC3 June 21st, 2019

Announcements

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) June 22nd, 2019

Ice lithography: opportunities and challenges in 3D nanofabrication June 21st, 2019

Researchers report new understanding of thermoelectric materials: Discovery leads to promising new materials for converting waste heat to power June 21st, 2019

Millions with neurological diseases could find new option in implantable neurostimulation devices June 21st, 2019

Tools

Millions with neurological diseases could find new option in implantable neurostimulation devices June 21st, 2019

University of Aberdeen use the Deben CT5000 to observe compressive damage mechanisms in syntactic foam June 14th, 2019

2D crystals conforming to 3D curves create strain for engineering quantum devices June 7th, 2019

nPoint piezo driven nanopositioning flexure stages now available from Elliot Scientific June 4th, 2019

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project